Matthew P. Young, EVP & CFO at Jazz Pharmaceuticals plc (JAZZ), sold 4,919 shares at $135.41 ($667K) on 2019-03-06, disclosed to the SEC on 2019-03-07.
Seasonal sale ($667k) by EVP & CFO — this insider has traded JAZZ in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $135.82 | 1,267 | $172K | 25.8% |
| 2 | $135.82 | 1,348 | $183K | 27.4% |
| 3 | $135.41 | 1,152 | $156K | 23.4% |
| 4 | $135.41 | 1,152 | $156K | 23.4% |
| Total | $135.63 avg | 4,919 | $667K | 100% |
| Filing → |
| JAZZ | SELL | 2018-10-17 | $221K | — | Filing → |
| JAZZ | SELL | 2018-09-19 | $228K | — | Filing → |
| JAZZ | SELL | 2018-08-16 | $246K | — | Filing → |